Intrinsic value of Tecogen - TGEN

Previous Close

$3.95

  Intrinsic Value

$0.17

stock screener

  Rating & Target

str. sell

-96%

Previous close

$3.95

 
Intrinsic value

$0.17

 
Up/down potential

-96%

 
Rating

str. sell

We calculate the intrinsic value of TGEN stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 0.1

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  48.60
  44.24
  40.32
  36.78
  33.61
  30.75
  28.17
  25.85
  23.77
  21.89
  20.20
  18.68
  17.31
  16.08
  14.97
  13.98
  13.08
  12.27
  11.54
  10.89
  10.30
  9.77
  9.29
  8.86
  8.48
  8.13
  7.82
  7.54
  7.28
  7.05
Revenue, $m
  49
  71
  100
  137
  182
  239
  306
  385
  476
  581
  698
  828
  972
  1,128
  1,297
  1,478
  1,672
  1,877
  2,093
  2,321
  2,560
  2,811
  3,072
  3,344
  3,628
  3,923
  4,229
  4,548
  4,879
  5,223
Variable operating expenses, $m
  43
  61
  85
  115
  153
  200
  255
  321
  397
  484
  579
  688
  807
  936
  1,077
  1,227
  1,387
  1,558
  1,738
  1,927
  2,125
  2,333
  2,550
  2,776
  3,011
  3,256
  3,510
  3,775
  4,050
  4,335
Fixed operating expenses, $m
  3
  3
  3
  3
  3
  3
  3
  4
  4
  4
  4
  4
  4
  4
  4
  4
  4
  4
  5
  5
  5
  5
  5
  5
  5
  5
  5
  6
  6
  6
Total operating expenses, $m
  46
  64
  88
  118
  156
  203
  258
  325
  401
  488
  583
  692
  811
  940
  1,081
  1,231
  1,391
  1,562
  1,743
  1,932
  2,130
  2,338
  2,555
  2,781
  3,016
  3,261
  3,515
  3,781
  4,056
  4,341
Operating income, $m
  4
  7
  12
  18
  26
  36
  47
  60
  76
  93
  115
  137
  161
  188
  216
  247
  280
  315
  351
  390
  430
  473
  517
  563
  611
  661
  713
  768
  824
  882
EBITDA, $m
  6
  10
  15
  22
  30
  40
  52
  67
  83
  102
  124
  147
  174
  202
  233
  266
  301
  338
  378
  419
  463
  509
  556
  606
  657
  711
  767
  825
  886
  948
Interest expense (income), $m
  0
  0
  1
  2
  3
  4
  6
  9
  11
  15
  18
  23
  27
  33
  39
  45
  52
  60
  68
  76
  85
  94
  104
  115
  125
  137
  148
  160
  173
  186
  200
Earnings before tax, $m
  4
  7
  11
  15
  22
  29
  38
  49
  61
  75
  92
  109
  128
  149
  171
  195
  220
  247
  275
  305
  336
  369
  403
  438
  475
  513
  553
  594
  638
  682
Tax expense, $m
  1
  2
  3
  4
  6
  8
  10
  13
  17
  20
  25
  30
  35
  40
  46
  53
  59
  67
  74
  82
  91
  100
  109
  118
  128
  139
  149
  161
  172
  184
Net income, $m
  3
  5
  8
  11
  16
  21
  28
  36
  45
  55
  67
  80
  94
  109
  125
  142
  161
  180
  201
  223
  245
  269
  294
  320
  347
  375
  404
  434
  465
  498

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  76
  109
  153
  210
  280
  367
  470
  591
  732
  892
  1,072
  1,272
  1,493
  1,733
  1,992
  2,271
  2,568
  2,883
  3,216
  3,566
  3,933
  4,317
  4,719
  5,137
  5,572
  6,025
  6,496
  6,986
  7,495
  8,023
Adjusted assets (=assets-cash), $m
  76
  109
  153
  210
  280
  367
  470
  591
  732
  892
  1,072
  1,272
  1,493
  1,733
  1,992
  2,271
  2,568
  2,883
  3,216
  3,566
  3,933
  4,317
  4,719
  5,137
  5,572
  6,025
  6,496
  6,986
  7,495
  8,023
Revenue / Adjusted assets
  0.645
  0.651
  0.654
  0.652
  0.650
  0.651
  0.651
  0.651
  0.650
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
  0.651
Average production assets, $m
  16
  23
  32
  44
  59
  78
  99
  125
  155
  189
  227
  269
  316
  367
  422
  480
  543
  610
  680
  754
  832
  913
  998
  1,087
  1,179
  1,275
  1,374
  1,478
  1,586
  1,698
Working capital, $m
  18
  26
  37
  50
  67
  88
  113
  142
  175
  214
  257
  305
  358
  415
  477
  544
  615
  691
  770
  854
  942
  1,034
  1,130
  1,231
  1,335
  1,443
  1,556
  1,674
  1,795
  1,922
Total debt, $m
  9
  21
  36
  56
  80
  109
  145
  187
  235
  290
  352
  421
  497
  579
  669
  765
  867
  975
  1,090
  1,210
  1,336
  1,469
  1,607
  1,750
  1,900
  2,056
  2,218
  2,387
  2,562
  2,743
Total liabilities, $m
  26
  38
  53
  72
  96
  126
  162
  203
  252
  307
  369
  438
  513
  596
  685
  781
  883
  992
  1,106
  1,227
  1,353
  1,485
  1,623
  1,767
  1,917
  2,073
  2,235
  2,403
  2,578
  2,760
Total equity, $m
  50
  72
  101
  138
  184
  240
  308
  388
  480
  585
  703
  835
  979
  1,137
  1,307
  1,490
  1,684
  1,891
  2,109
  2,339
  2,580
  2,832
  3,095
  3,370
  3,655
  3,953
  4,262
  4,583
  4,916
  5,263
Total liabilities and equity, $m
  76
  110
  154
  210
  280
  366
  470
  591
  732
  892
  1,072
  1,273
  1,492
  1,733
  1,992
  2,271
  2,567
  2,883
  3,215
  3,566
  3,933
  4,317
  4,718
  5,137
  5,572
  6,026
  6,497
  6,986
  7,494
  8,023
Debt-to-equity ratio
  0.190
  0.290
  0.360
  0.400
  0.430
  0.460
  0.470
  0.480
  0.490
  0.500
  0.500
  0.500
  0.510
  0.510
  0.510
  0.510
  0.510
  0.520
  0.520
  0.520
  0.520
  0.520
  0.520
  0.520
  0.520
  0.520
  0.520
  0.520
  0.520
  0.520
Adjusted equity ratio
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656
  0.656

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  3
  5
  8
  11
  16
  21
  28
  36
  45
  55
  67
  80
  94
  109
  125
  142
  161
  180
  201
  223
  245
  269
  294
  320
  347
  375
  404
  434
  465
  498
Depreciation, amort., depletion, $m
  2
  3
  3
  3
  4
  5
  6
  7
  8
  9
  9
  11
  12
  14
  16
  19
  21
  24
  27
  29
  33
  36
  39
  42
  46
  50
  54
  58
  62
  66
Funds from operations, $m
  5
  7
  11
  15
  20
  26
  33
  42
  52
  64
  76
  90
  106
  123
  141
  161
  182
  204
  227
  252
  278
  305
  333
  362
  393
  424
  457
  492
  527
  564
Change in working capital, $m
  6
  8
  11
  14
  17
  21
  25
  29
  34
  38
  43
  48
  53
  58
  62
  67
  71
  75
  80
  84
  88
  92
  96
  100
  104
  109
  113
  117
  122
  127
Cash from operations, $m
  -1
  -1
  0
  1
  3
  5
  9
  13
  19
  25
  33
  42
  53
  66
  79
  94
  111
  129
  148
  168
  190
  213
  237
  262
  288
  316
  345
  374
  405
  438
Maintenance CAPEX, $m
  0
  -1
  -1
  -1
  -2
  -2
  -3
  -4
  -5
  -6
  -7
  -9
  -11
  -12
  -14
  -16
  -19
  -21
  -24
  -27
  -29
  -33
  -36
  -39
  -42
  -46
  -50
  -54
  -58
  -62
New CAPEX, $m
  -5
  -7
  -9
  -12
  -15
  -18
  -22
  -26
  -30
  -34
  -38
  -42
  -47
  -51
  -55
  -59
  -63
  -67
  -70
  -74
  -78
  -81
  -85
  -88
  -92
  -96
  -100
  -104
  -108
  -112
Cash from investing activities, $m
  -5
  -8
  -10
  -13
  -17
  -20
  -25
  -30
  -35
  -40
  -45
  -51
  -58
  -63
  -69
  -75
  -82
  -88
  -94
  -101
  -107
  -114
  -121
  -127
  -134
  -142
  -150
  -158
  -166
  -174
Free cash flow, $m
  -7
  -8
  -10
  -12
  -14
  -15
  -16
  -16
  -16
  -15
  -13
  -9
  -4
  2
  10
  19
  29
  41
  54
  68
  83
  99
  116
  135
  154
  174
  195
  217
  240
  264
Issuance/(repayment) of debt, $m
  9
  12
  15
  19
  24
  30
  36
  42
  48
  55
  62
  69
  76
  83
  89
  96
  102
  108
  114
  120
  126
  132
  138
  144
  150
  156
  162
  168
  175
  182
Issuance/(repurchase) of shares, $m
  14
  17
  21
  26
  30
  35
  40
  44
  48
  50
  51
  52
  51
  49
  45
  40
  34
  26
  17
  7
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  23
  29
  36
  45
  54
  65
  76
  86
  96
  105
  113
  121
  127
  132
  134
  136
  136
  134
  131
  127
  126
  132
  138
  144
  150
  156
  162
  168
  175
  182
Total cash flow (excl. dividends), $m
  16
  20
  26
  33
  41
  50
  59
  69
  80
  91
  100
  112
  123
  134
  145
  155
  165
  176
  185
  195
  209
  231
  254
  278
  304
  330
  357
  386
  415
  446
Retained Cash Flow (-), $m
  -16
  -22
  -29
  -37
  -46
  -57
  -68
  -80
  -92
  -105
  -118
  -131
  -145
  -157
  -170
  -183
  -195
  -207
  -218
  -230
  -241
  -252
  -263
  -274
  -286
  -297
  -309
  -321
  -334
  -347
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  -1
  -2
  -3
  -4
  -5
  -7
  -9
  -10
  -12
  -14
  -18
  -20
  -22
  -24
  -26
  -28
  -29
  -31
  -33
  -35
  -32
  -21
  -9
  4
  18
  33
  48
  64
  81
  99
Discount rate, %
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
  -1
  -2
  -2
  -3
  -4
  -5
  -6
  -6
  -7
  -7
  -8
  -8
  -8
  -8
  -8
  -7
  -6
  -6
  -5
  -4
  -3
  -2
  -1
  0
  1
  1
  1
  1
  1
  1
Current shareholders' claim on cash, %
  87.6
  78.4
  71.3
  65.6
  61.0
  57.3
  54.3
  51.8
  49.7
  48.0
  46.6
  45.5
  44.6
  43.8
  43.2
  42.8
  42.5
  42.2
  42.1
  42.1
  42.1
  42.1
  42.1
  42.1
  42.1
  42.1
  42.1
  42.1
  42.1
  42.1

Tecogen Inc. designs, manufactures, sells and maintains cogeneration products, including combined heat and power (CHP), air conditioning systems and water heaters for residential, commercial, recreational and industrial use. The Company is engaged in the business of manufacturing and supporting CHP products based on engines fueled by natural gas. The Company manufactures over three types of CHP products, such as cogeneration units that supply electricity and hot water, chillers that provide air-conditioning and hot water, and water heaters. Its commercial product line includes the InVerde, InVerde e+ and TECOGEN cogeneration units; TECOCHILL chillers; Ilios high-efficiency water heaters, and Ultera emissions control technology. Its customers include hospitals and nursing homes, hotels and motels, office and retail buildings, and military installations. Its cogeneration systems and chillers use the engine, the TecoDrive 7400 model.

FINANCIAL RATIOS  of  Tecogen (TGEN)

Valuation Ratios
P/E Ratio -78.9
Price to Sales 3.3
Price to Book 5.3
Price to Tangible Book
Price to Cash Flow -26.3
Price to Free Cash Flow -26.3
Growth Rates
Sales Growth Rate 14.3%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate NaN%
Cap. Spend. - 3 Yr. Gr. Rate -100%
Financial Strength
Quick Ratio NaN
Current Ratio 0
LT Debt to Equity 20%
Total Debt to Equity 20%
Interest Coverage 0
Management Effectiveness
Return On Assets -4.4%
Ret/ On Assets - 3 Yr. Avg. -15.5%
Return On Total Capital -5.9%
Ret/ On T. Cap. - 3 Yr. Avg. -22.1%
Return On Equity -7.1%
Return On Equity - 3 Yr. Avg. -33.4%
Asset Turnover 1.1
Profitability Ratios
Gross Margin 37.5%
Gross Margin - 3 Yr. Avg. 35.7%
EBITDA Margin -4.2%
EBITDA Margin - 3 Yr. Avg. -13.2%
Operating Margin -4.2%
Oper. Margin - 3 Yr. Avg. -13.2%
Pre-Tax Margin -4.2%
Pre-Tax Margin - 3 Yr. Avg. -13.2%
Net Profit Margin -4.2%
Net Profit Margin - 3 Yr. Avg. -13.2%
Effective Tax Rate 0%
Eff/ Tax Rate - 3 Yr. Avg. 0%
Payout Ratio 0%

TGEN stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the TGEN stock intrinsic value calculation we used $33.202666 million for the last fiscal year's total revenue generated by Tecogen. The default revenue input number comes from 0001 income statement of Tecogen. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our TGEN stock valuation model: a) initial revenue growth rate of 48.6% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for TGEN is calculated based on our internal credit rating of Tecogen, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Tecogen.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of TGEN stock the variable cost ratio is equal to 87.9%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $3 million in the base year in the intrinsic value calculation for TGEN stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 7.8% for Tecogen.

Corporate tax rate of 27% is the nominal tax rate for Tecogen. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the TGEN stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for TGEN are equal to 32.5%.

Life of production assets of 25.6 years is the average useful life of capital assets used in Tecogen operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for TGEN is equal to 36.8%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $33.239534 million for Tecogen - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 24.82 million for Tecogen is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Tecogen at the current share price and the inputted number of shares is $0.1 billion.

RELATED COMPANIES Price Int.Val. Rating
CSWI CSW Industrial 53.02 37.15  sell
PFIE Profire Energy 2.29 7.01  str.buy

COMPANY NEWS

▶ Tecogen Announces Third Quarter 2018 Results   [09:00AM  GlobeNewswire]
▶ Tecogen Inc. to Host Earnings Call   [Aug-14-18 09:00AM  ACCESSWIRE]
▶ Tecogen's Q2 Earnings Preview   [Aug-13-18 02:35PM  Benzinga]
▶ Tecogen Rolls Out New Tecopower CHP Product   [Jun-14-18 09:00AM  GlobeNewswire]
▶ Tecogen InVerde CHP Platform Reaches Operational Milestone   [Jun-06-18 09:00AM  GlobeNewswire]
▶ UPDATE: Tecogen Announces First Quarter 2018 Results   [May-15-18 10:24AM  GlobeNewswire]
▶ Tecogen Announces First Quarter 2018 Results   [09:00AM  GlobeNewswire]
▶ Is Tecogen Inc (NASDAQ:TGEN) A Financially Sound Company?   [Apr-11-18 05:19PM  Simply Wall St.]
▶ Tecogen to Present Paper at SAE World Congress   [Apr-10-18 10:40AM  Marketwired]
▶ Boston-area Ice Rink Orders Second Chiller   [Mar-27-18 08:00AM  Marketwired]
▶ Tecogen Inc. to Host Earnings Call   [09:00AM  ACCESSWIRE]
▶ Brooklyn Manufacturing Company Orders 2 InVerde e+ Units   [Feb-15-18 08:00AM  Marketwired]
▶ Tecogen Announces Creation of Ultera Technologies, Inc.   [Dec-13-17 08:00AM  Marketwired]
▶ Is It Too Late To Buy Tecogen Inc (TGEN)?   [Nov-21-17 06:49PM  Simply Wall St.]
▶ Tecogen Announces Third Quarter 2017 Results   [Nov-09-17 09:00AM  Marketwired]
▶ Tecogen Dissolves ULTRATEK Joint Venture   [Oct-26-17 08:04AM  Marketwired]
▶ Tecogen to hold Ultratek Update Conference Call   [Oct-13-17 02:45PM  Marketwired]
▶ Ontario Cucumber Grower Teams Up With Tecogen   [Oct-12-17 08:00AM  Marketwired]
▶ Manhattan Co-op Chooses InVerde e+ Power   [Sep-27-17 08:00AM  Marketwired]
▶ Cannabis Order Book Grows Higher   [Sep-20-17 08:00AM  Marketwired]
▶ Tecogen Secures 10-Unit InVerde e+ Order   [Sep-06-17 08:00AM  Marketwired]
▶ Laundromat Chooses Tecogen for Clean(ing) Power   [Aug-30-17 08:00AM  Marketwired]
▶ Tecogen Announces Second Quarter 2017 Results   [Aug-14-17 08:45AM  Marketwired]
▶ Chiller Sale to Repeat Customer in Boise, Idaho   [Aug-10-17 08:00AM  Marketwired]
▶ Maine Fitness Club Makes Ilios its Choice for Hot Water   [Aug-01-17 08:00AM  Marketwired]
▶ 5 of the Best Stocks Under $10 for 2017   [Jul-05-17 12:54PM  Zacks]
▶ 5 of the Best Stocks Under $10 for 2017   [Jun-01-17 02:38PM  Zacks]
▶ Tecogen Appoints New Executives   [May-25-17 09:00AM  Marketwired]
▶ Tecogen and American DG Complete Merger   [May-18-17 05:02PM  Marketwired]
▶ Tecogen And American DG Complete Merger   [04:55PM  PR Newswire]
▶ Tecogen Announces Merger S-4 Effective by SEC   [Apr-13-17 09:25AM  PR Newswire]
▶ Tecogen Presenting at SAE World Congress   [Apr-04-17 09:52AM  PR Newswire]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.